Suven Pharms Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SUVEN PHARMS, and what generic and branded alternatives to SUVEN PHARMS drugs are available?
SUVEN PHARMS has four approved drugs.
Summary for Suven Pharms
| US Patents: | 0 |
| Tradenames: | 4 |
| Ingredients: | 4 |
| NDAs: | 4 |
Drugs and US Patents for Suven Pharms
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Suven Pharms | MALATHION | malathion | LOTION;TOPICAL | 091559-001 | May 23, 2012 | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | |||||
| Suven Pharms | GLYCOPYRROLATE | glycopyrrolate | SOLUTION;ORAL | 212467-001 | Jul 5, 2022 | AA | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Suven Pharms | CHLOROQUINE PHOSPHATE | chloroquine phosphate | TABLET;ORAL | 214756-001 | Sep 3, 2021 | AA | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Suven Pharms | CALCIUM ACETATE | calcium acetate | CAPSULE;ORAL | 211038-001 | Feb 21, 2020 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
